drugset / Trial / NCT00684190

Drug Interaction Study Between AZD3355 and Nexium

NCT00684190

Phase 1 Completed 30 enrolled AstraZeneca
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of the study is to evaluate if AZD3355 and Nexium interact with each other or not, i.e. show the same or altered plasma concentration profiles when co-administered compared to administered alone.

Timeline

Start
2008-03
Primary completion
2008-06
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Esomeprazole Small molecule 40 mg Oral
Subject lesogaberan Small molecule 150 mg Oral